Hair Loss Treatment Market Witnessing Significant Growth with Increasing Incidence of Alopecia Areata
Hair loss can be caused by numerous disorders. Alopecia areata or hair loss begins after the onset of puberty. Alopecia is a common autoimmune disorder that often results in unpredictable hair loss on the scalp, face, and other areas of the body. Thus, with the increasing incidence of alopecia areata, the demand for hair loss treatment is also increasing, driving the hair loss treatment growth. For instance, in March 2020, Eli Lilly and Company and Incyte Corporation announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to baricitinib for the treatment of alopecia areata. In April 2020, Phyto launched new anti-hair loss products, such as Phytonovathrix Global Anti-Hair Loss Treatment, Pyhtonovathrix Fortifying Energizing Shampoo, and Phytonovathrix Hair Energising Mass Lotion, which leverage on the 'wnt protein', to trigger the growth cycle. Hair loss is more common in men. It is most prominent in the vertex and frontotemp...